Skip to content
Leases
Industrial
Office
Retail
All Leases
Deals of the Week
Finance
Acquisition
CMBS
Construction
Distress
Refinance
All Finance
Deals of the Week
Sales
Residential
Commercial
Mixed Use
Land
Hotels
Development Rights
All Sales
Deals of the Week
Design + Construction
Architecture
Construction
Infrastructure
Policy
Urban Planning
Neighborhoods
All Design + Construction
Technology
More
Analysis
Columnists
Features
Industry
IMPACT
Legal
Partner Insights
Players
Research
Tenant Talk
Transportation
Markets
Los Angeles
New York City
Manhattan
Brooklyn
Queens
Bronx
National
Washington DC
South Florida
Videos
Power Briefing
Leasing + Sales Q&A
Design + Construction Q&A
On-Demand Events
All Videos
Weekly Issue
Events
Power Series
Log In
Sign Up
My Account
Log Out
Account Details
Email Preferences
Member FAQs
Logout
Search
Leases
Industrial
Office
Retail
All
Deals of the Week
Finance
Acquisition
Construction
CMBS
Distress
Refinance
All
Deals of the Week
Sales
Residential
Commercial
Mixed Use
Land
Hotels
Development Rights
All
Deals of the Week
Design + Construction
Architecture
Construction
Infrastructure
Policy
Urban Planning
Neighborhoods
All
Technology
More
Features
Columnists
Analysis
Research
Partner Insights
Industry
Legal
Players
Transportation
All
Markets
Los Angeles
New York City
Manhattan
Brooklyn
Queens
Bronx
National
Washington DC
South Florida
Videos
Power Briefing
Leasing + Sales Q&A
Design + Construction Q&A
On-Demand Events
All Videos
Weekly Issue
Events
IMPACT
Advertise
Contact
Reprints
Newsletters
Power Finance
Power 100
Owners Magazine
Log In
Sign Up
My Account
Log Out
Account Details
Email Preferences
Member FAQs
Logout
© 2024 Observer Media ·
Terms
·
Privacy
biopharmacy
Finance
·
Analysis
National
Life Sciences Sales Crater, but Demand Expected to Rebound: Report
By
Brian Pascus
Premium
